Analyst David Risinger of Leerink Partners reiterated a Buy rating on Eli Lilly & Co (LLY – Research Report), retaining the price target of $970.00. Don't Miss our Black Friday Offers: David Risinger ...
Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...
The new mens range debuted at a VIP fashion show in Palm Beach last week, and will arrive in stores in February for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback